FDA Approved: OGSIVEO — Supplemental Application (SpringWorks Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OGSIVEO (nirogacestat) from SpringWorks Therapeutics, expanding the drug's approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• OGSIVEO (NIROGACESTAT)

Snippet

SUPPL AP for OGSIVEO (NIROGACESTAT)